* Core Laboratories NV CLB.N reported quarterly adjusted
earnings of 20 cents per share for the quarter ended in
December. The mean expectation of ten analysts for the quarter
was for earnings of 20 cents per share.
* Revenue rose 10% to $125.14 million from a year ago;
analysts
expected $122.37 million.
* Core Laboratories NV's reported EPS for the quarter was 6
cents.
* The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* Core Laboratories NV shares had risen by 24.1% this
quarter.
* The company reported quarterly net income of $2.69
million.
* Wall Street's median 12-month price target for Core
Laboratories
NV is $28.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and 2 "sell" or "strong sell."
This summary was machine generated February 3 at 12:02 a.m.
All figures in US dollars unless otherwise stated